Brief: Algernon Explores The Use Of NP-120 As A Novel Treatment For Coronavirus
06/03/2020 11:28
March 6 (Reuters) - Algernon Pharmaceuticals Inc AGN.CD :
* ALGERNON EXPLORES THE USE OF NP-120 (IFENPRODIL) AS A
NOVEL
TREATMENT FOR CORONAVIRUS
Source text for Eikon: ID:nGNXbbV3qk
Further company coverage: AGN.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grey Matters Health
See all newsBrief: Grey Matters Announces The Closing Of Its Equity And Convertible Debenture Private Placement Totalling CAD $1.12 Million
Brief: Algernon Announces Additional Increase To Private Placement Financing
Brief: Algernon Health Announces Private Placement
Brief: Algernon Announces Closing Of The Private Placement Financing
Brief: Algernon Announces $1 Mln Private Placement